INTENSITY THERAPEUTICS, INC. (INTS) AI Stock Price Forecast & Investment Analysis
Latest Analysis Date: August 22, 2025
INTENSITY THERAPEUTICS, INC. (INTS) - Comprehensive Stock Analysis & Investment Research
Company Overview & Business Profile
INTENSITY THERAPEUTICS, INC. (Stock Symbol: INTS)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
The organization employs approximately 9 professionals worldwide
.
The company has established itself as
an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Market Capitalization: $8 million - Classified as a
small-cap investment offering high growth potential.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for INTENSITY THERAPEUTICS, INC. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
INTENSITY THERAPEUTICS, INC. strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
representing an emerging small-cap investment with substantial growth potential and market disruption capabilities
.
.
INTENSITY THERAPEUTICS, INC. Stock Price Chart and Technical Analysis
Loading chart data...
Loading INTENSITY THERAPEUTICS, INC. interactive price chart and technical analysis...
Deep dive into INTENSITY THERAPEUTICS, INC.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if INTENSITY THERAPEUTICS, INC. stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For INTENSITY THERAPEUTICS, INC.: With a P/E ratio of -2.18, the market sees the stock as potentially undervalued.
P/E Ratio-2.18x
P/B Ratio3.64x
Market Cap$8M
EPS$-0.62
Book Value/Share$0.08
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently INTENSITY THERAPEUTICS, INC. converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For INTENSITY THERAPEUTICS, INC.:
Understanding Financial Health Metrics
What these metrics mean: These ratios assess INTENSITY THERAPEUTICS, INC.'s ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For INTENSITY THERAPEUTICS, INC.:
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal INTENSITY THERAPEUTICS, INC.'s ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For INTENSITY THERAPEUTICS, INC.:
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively INTENSITY THERAPEUTICS, INC. uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For INTENSITY THERAPEUTICS, INC.:
Understanding Financial Statement Data
What these metrics mean: Key figures from INTENSITY THERAPEUTICS, INC.'s income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For INTENSITY THERAPEUTICS, INC.:
Income Statement ($ Millions)
R&D Expense$10M
Balance Sheet Highlights ($ Millions)
Dividend & Shareholder Information
Shares Outstanding26M
Growth Metrics (YoY)
EPS Growth-47.7%
INTENSITY THERAPEUTICS, INC. (INTS) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for INTENSITY THERAPEUTICS, INC. stock analysis.
Loading fundamental data...
Loading INTENSITY THERAPEUTICS, INC. comprehensive fundamental analysis and insider trading data...
Latest INTENSITY THERAPEUTICS, INC. Stock News & Market Analysis
Breaking news, analyst reports, and market updates affecting INTENSITY THERAPEUTICS, INC. (INTS) stock price and investment outlook.
--Intensity Therapeutics, Inc., a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to ...
Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies ...
Intensity Therapeutics, Inc. Announces the Closing and Full Exercise of the Over-Allotment Option from its Upsized Initial Public Offering, Raising a Total of $22.425 Million in Gross Proceeds ...
Intensity Therapeutics shareholders elect director and approve auditor at annual meeting Intensity Therapeutics , Inc. (NASDAQ:INTS), a micro-cap biotech company currently valued at $8.36 million ...
SHELTON, Conn., May 28, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS), ("Intensity" or "the Company") a late-stage clinical biotechnology company focused on the discovery and ...
May 15, 2024 8:01 AM ETIntensity Therapeutics, Inc. (INTS) INT230-6, Intensity's lead proprietary investigational product candidate, is designed for direct intratumoral injection. INT230-6 was ...
SHELTON, Conn., June 30, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and ...
Intensity Therapeutics, Inc. (Nasdaq: INTS), ("Intensity" or the "Company") a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based ...
Intensity Therapeutics, Inc. Appoints Ian B. Walters M.D., MBA as Vice President and Chief Medical Officer September 03, 2014 07:36 AM Eastern Daylight Time ...
Intensity Therapeutics, Inc. Raises $6.6 Million from At The Market Offering (ATM) Stock Sales in July 2025 News provided by Intensity Therapeutics Inc. Aug 04, 2025, 7:47 AM ET ...
Intensity Therapeutics, Inc. (Nasdaq: INTS), ("Intensity" or the "Company") a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based ...
Intensity Therapeutics, Inc. Raises $6.6 Million from At The Market Offering (ATM) Stock Sales in July 2025 News provided by Intensity Therapeutics Inc. Aug 04, 2025, 7:47 AM ET ...
INTENSITY THERAPEUTICS, INC. Competitors & Peer Analysis - Life Sciences Sector
Comparative analysis of INTENSITY THERAPEUTICS, INC. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
Frequently Asked Questions - INTENSITY THERAPEUTICS, INC. Stock Forecast
How accurate are INTENSITY THERAPEUTICS, INC. stock predictions?
Our AI model demonstrates 57% historical accuracy for INTS predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence INTENSITY THERAPEUTICS, INC. stock price forecasts?
Is INTENSITY THERAPEUTICS, INC. a good investment in 2025?
Based on our AI analysis, INTENSITY THERAPEUTICS, INC. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are INTENSITY THERAPEUTICS, INC. forecasts updated?
INTENSITY THERAPEUTICS, INC. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced INTENSITY THERAPEUTICS, INC. Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for INTENSITY THERAPEUTICS, INC. stock.
